Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Bystrom

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Cytokine|September 19, 2016
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseasesJonas Bystrom, F I Clanchy, Taher E Taher, et al.
Clinical Reviews in Allergy & Immunology|May 1, 2017
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and AutoimmunityTaher E Taher, Jonas Bystrom, Voon H Ong, et al.
Clinical and Molecular Allergy : CMA|April 14, 2020
Evidence for eosinophil and IL-17 mediated inflammation in allergic rhinitisKawa Amin, Sulaf Mosa Issa, Kosar Mohammad Ali, et al.
Blood|October 21, 2011
Transcriptomic analyses of murine resolution-phase macrophagesMelanie J Stables, Sonia Shah, Evelyn B Camon, et al.
Rheumatology (Oxford, England)|September 28, 2020
TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20Mohammed Al-Bogami, Jonas Bystrom, Felix Clanchy, et al.
FEBS Letters|August 5, 2010
A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitisTie Zheng Hou, Jonas Bystrom, Jonathan P Sherlock, et al.
Blood|January 26, 2008
Novel biphasic role for lymphocytes revealed during resolving inflammationRavindra Rajakariar, Toby Lawrence, Jonas Bystrom, et al.
Plos One|September 24, 2013
Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease?Jonas Bystrom, Scott J Thomson, Jörgen Johansson, et al.
Mediators of Inflammation|June 24, 2015
Harnessing the Therapeutic Potential of Th17 CellsJonas Bystrom, Taher E Taher, M Sherwan Muhyaddin, et al.
Saudi Medical Journal|November 24, 2015
Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronateMohammed M Al-Bogami, Mohammed A Alkhorayef, Jonas Bystrom, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Cytokine|September 19, 2016
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseasesJonas Bystrom, F I Clanchy, Taher E Taher, et al.
Clinical Reviews in Allergy & Immunology|May 1, 2017
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and AutoimmunityTaher E Taher, Jonas Bystrom, Voon H Ong, et al.
Clinical and Molecular Allergy : CMA|April 14, 2020
Evidence for eosinophil and IL-17 mediated inflammation in allergic rhinitisKawa Amin, Sulaf Mosa Issa, Kosar Mohammad Ali, et al.
Blood|October 21, 2011
Transcriptomic analyses of murine resolution-phase macrophagesMelanie J Stables, Sonia Shah, Evelyn B Camon, et al.
Rheumatology (Oxford, England)|September 28, 2020
TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20Mohammed Al-Bogami, Jonas Bystrom, Felix Clanchy, et al.
FEBS Letters|August 5, 2010
A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitisTie Zheng Hou, Jonas Bystrom, Jonathan P Sherlock, et al.
Blood|January 26, 2008
Novel biphasic role for lymphocytes revealed during resolving inflammationRavindra Rajakariar, Toby Lawrence, Jonas Bystrom, et al.
Plos One|September 24, 2013
Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease?Jonas Bystrom, Scott J Thomson, Jörgen Johansson, et al.
Mediators of Inflammation|June 24, 2015
Harnessing the Therapeutic Potential of Th17 CellsJonas Bystrom, Taher E Taher, M Sherwan Muhyaddin, et al.
Saudi Medical Journal|November 24, 2015
Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronateMohammed M Al-Bogami, Mohammed A Alkhorayef, Jonas Bystrom, et al.
Pageof 4